stockchase picture

Compiling comments that experts make about stocks while on public TV.


Opinion for Abbott Labs (ABT-N)

Signal Price Bias Subject Owned

This has been one of the strong companies in the ethical drug companies. Have grown their dividend 10% at year over the last 10 years. Has been a very steady company. Traded sideways for 12 years in a price range and recently in the last year, broke out. They are going to split this company into a medical products/devices company and a pure pharma business. The pharma business will have a high yield attached and the other part has opportunities for efficiencies and growth.

David Burrows
President, Barometer Capital Management

No Comments.

You must be logged in to comment.